United Kingdom

People: Diplomat Pharmacy Inc (DPLO.N)

DPLO.N on New York Stock Exchange

23 Aug 2019
Change (% chg)

$-0.12 (-2.09%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Griffin, Brian 

Mr. Brian T. Griffin is Chairman of the Board, Chief Executive Officer of the Company. He has more than 30 years of experience as a results-driven healthcare executive. Mr. Griffin's dynamic skillset is rooted in deep expertise in pharmacy benefit management, specialty pharmacy, and health plan leadership. he served since March 2018 as executive vice president and CEO for IngenioRx, the pharmacy benefit manager he led the building and launch of for Anthem. For the previous three years, Mr. Griffin led Anthem's commercial and specialty business division. He joined the company in 2013 as president and CEO of its second-largest affiliated health plan, Empire BlueCross BlueShield. Before his time with Anthem, he spent 25 years at Medco Health Solutions, which was acquired by Express Scripts in 2012. In more than a decade as president of Medco's health plan division, Mr. Griffin managed relationships with national and regional health plans, BlueCross BlueShield plans, commercial insurance carriers, consumer-driven plans, and third-party administrators. Mr. Griffin has extensive managerial, operating, regulatory, compliance, financial and accounting experience, and expertise, including significant experience in driving growth through acquisitions and organically, from his various executive management positions. In particular, his services as an executive for over 35 years in the healthcare industry, including more than five years as a leading executive at one of the largest health benefits companies in the United States and 10 years as a leading executive for a provider of specialty pharmaceutical services, provides him critical industry insight and relationships and related operations, strategic, marketing, acquisition, and senior leadership expertise

Basic Compensation

Total Annual Compensation, USD 669,231
Restricted Stock Award, USD 7,674,040
Long-Term Incentive Plans, USD --
All Other, USD 1,428,620
Fiscal Year Total, USD 9,771,880

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --